The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Possible therefore to see FY24 EPS of around 37p-38p hence still on 5.5x forward.
Good progress on the £2bn operating savings as well.
I think the £10bn buyback is becoming more credible, assuming this happens stock could be nearer 350p ps.
That guy has been the source of almost 100% of the drama around this co from day 1, an absolute nightmare- if the Ukraine govt seize his shareholding then cannot be any worse than having him there
I agree they are a good airline, that is priced in - the issue is the volatile cash level
Yeah but the world is drastically different to 2019 - co's have to hold more cash, the price of debt has rocketed
Whilst I agree in theory, Jet2 has never done a special dividend or share buyback -
A321 Neo are about US$140m each so that explains £220m but reduction is c. £820m
Jet2 own cash has fallen from £2.12bn (30 Sept 23) to £1.3bn - any info as to why?
I like your bullishness however am struggling to share it, because until the prelims are out the whole spectre of the lack of accounts sign off is paramount. The Ukraine govt has been milking this co with all sorts of tricks and wheezes, it is not a situation that has any clarity.
Is there any specific reason why it is up today?
True, dismayed at the response, suppose need to see what happens to that US$125m
Interesting perspective - however my understanding is the case was against Mead Johnson USA- the subsidiary - hence would the jury not have thought the defendants were American
The problem with the board having its hands full argument is it is not plausible - putting the results out and having a few zoom meetings - it will be done in a day maybe two maximum. The legal problems are ongoing and not going to be cleared in a few days anyway.
So what has been achieved here? i) panicking investors and making decisions that will panic s/h ii) draining confidence in the BoD iii) it is not entirely clear if a) FPM are unable to pay due to insufficient cash, provisioning for liabilities or b) unable to pay due to legal sanction.
What is also confusing are ongoing statements about FPM continuing to operate and being unaffected - it appears to be very affected.
Maybe you never know , disappointing, one drama after another this outfit
This latest drama is totally self inflicted and really poor decision making - especially given that no one was expecting a dividend in the first place- then they go throwing chicken at crocodiles and now reversing again.
Yeah why have clarity and honesty when the alternative option available is to B/S people. Isn't the stress of the war enough without this sort of ham fisted rubbish?
Last time I recall anyone doing this was BP in 2010 after the Macondo spill - the stock had gone XD and BP cancelled to retain cash.
This sort of thing really should only happen in disaster scenarios and this obviously leaves a bad taste.
Some more clarity on the lurches from one legal crisis to another would be helpful.
HSBC were offered SVB UK, it was served up on a plate - Barclays were not, so not the board's fault
It all adds up to a really poor outcome for something that started with so much promise- America does tech. London does not do tech- full stop
I suppose the reasoning behind this, the bear point is if the Verne sale is blocked then that is problematic.
A bit surprised (pleasantly) at this turn of events. Cash cost of $19.3m is material to existing cash balances ($109m).
Again somewhat out of the blue given most recent co statement and interim net profit of US$27m. Reality is possibly less altruistic, Zhevago possibly needs the cash.